Refile: UPDATE 1-Diagnostics group DiaSorin's nine-month adjusted core profit up 6%

DiaSorin SpA

05/11/2024 16:48

(Adds revenue, guidance)
       Nov 5 (Reuters) - Italian medical diagnostics group
DiaSorin  DIAS.MI  on Tuesday posted a 6% jump in nine-month
adjusted core profit to 292 million euros ($318.46 million) at
constant exchange rates,  driven by its immunodiagnostic
segment.
    The group's nine-month overall revenue grew to 583 million
euros compared to last year's results of 846 million euros,
driven by the excellent performance of CLIA speciality tests in
the immunodiagnostics segment, which rose 10% yearly, the
company said in a statement.
    It slightly lifted its 2024 revenue guidance, forecasting
now a 7% increase in ex-Covid revenues, instead of the
previously expected increase between 6 and 7%. The company
confirmed its guidance of a 33% increase in adjusted core profit
margin. 
     
    ($1 = 0.9169 euros)

(Reporting by Michela Stasio in Gdansk
Editing by David Goodman, Alexandra Hudson)
((michela.stasio@thomsonreuters.com))